Jiangsu Hengrui Pharmaceuticals Co Ltd

600276.SS · Health Technology · Pharmaceuticals: Major · CN

20,636 employees · hengrui.com

About

Jiangsu Hengrui Pharmaceuticals Co Ltd, headquartered in Lianyungang, China, operates in the Health Care sector, specializing in Pharmaceuticals. The company researches, develops, manufactures, and sells a range of drugs including antineoplastic agents, angiomyocardiac medications, surgical drugs, contrast agents, antibiotics, and specialty infusions. With 20,636 employees, it serves both domestic and international markets, having been listed on the stock exchange in 2000.

Annual results

Reported figures, CNY · revenue up 12.3% in 2025

YearRevenueNet incomeNet marginFree cash flow
202531.4B7.7B24.5%—
202428.0B6.3B22.6%—
202322.8B4.3B18.9%—
202221.3B3.9B18.4%—
202125.9B4.5B17.5%—

Dividends per share

2026 0.20 CNY2025 0.20 CNY2024 0.20 CNY2023 0.16 CNY2022 0.16 CNY

600276.SS in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Jiangsu Hengrui Pharmaceuticals Co Ltd are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Jiangsu Hengrui Pharmaceuticals Co Ltd (600276.SS) — company profile and financials · MarketPulse